Skip to content

Clinical trials

Fibrosis trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fibrosis Country / region: Japan Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20092
20101
20111
20141
20171
20221
20231
20243
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting3
Active, not recruiting2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Co., Ltd.4
GlaxoSmithKline2
89bio, Inc.1
AbbVie1
AstraZeneca1
Bristol-Myers Squibb1
Komagome Hospital1
National Center for Global Health and Medicine, Japan1
Pulmovant, Inc.1
aTyr Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fibrosis14
Ascites4
Fatty Liver3
Lung Diseases, Interstitial3
Non-alcoholic Fatty Liver Disease3
Hepatitis C2
Sarcoidosis2
Acquired Immunodeficiency Syndrome1
Arthritis, Rheumatoid1
Cardiovascular Diseases1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.